Browse by Journal Title

Article

TAAR9 knockout increases hippocampal serotonin and alters grooming behavior in rats.
Zhukov, Ilya S., Karpova, Inessa V., Murtazina, Ramilya Z., Alnefeesi, Yazen, Korenkova, Olga M., Tissen, Ilia Yu, Palchikova, Svetlana A., Tokareva, Lydia A., Pyurveev, Sarng S., Shabanov, Petr D., Kubarskaya, Larisa G., Rozhko, Mikhail A., Zernova, Ekaterina B., Zolotoverkhaja, Ekaterina A., Volnova, Anna B., Kalueff, Allan V., Alenina, Natalia V. and Gainetdinov, Raul R.
Frontiers in Pharmacology 16 : 1684029. 12 November 2025

A comparison of nine machine learning mutagenicity models and their application for predicting pyrrolizidine alkaloids.
Helma, C., Schöning, V., Drewe, J. and Boss, P.
Frontiers in Pharmacology 12 : 708050. 22 July 2021

TRPM8 activation via 3-iodothyronamine blunts VEGF-induced transactivation of TRPV1 in human uveal melanoma cells.
Walcher, L., Budde, C., Böhm, A., Reinach, P.S., Dhandapani, P., Ljubojevic, N., Schweiger, M.W., von der Waydbrink, H., Reimers, I., Köhrle, J. and Mergler, S.
Frontiers in Pharmacology 9 : 1234. 13 November 2018

Investigation of naturally occurring single-nucleotide variants in human TAAR1.
Muehlhaus, J., Dinter, J., Jyrch, S., Teumer, A., Jacobi, S.F., Homuth, G., Kuehnen, P., Wiegand, S., Grueters, A., Voelzke, H., Raile, K., Kleinau, G., Krude, H. and Biebermann, H.
Frontiers in Pharmacology 8 : 807. 24 November 2017

Advancing cardiovascular, neurovascular, and renal magnetic resonance imaging in small rodents using cryogenic radiofrequency coil technology.
Niendorf, T., Pohlmann, A., Reimann, H.M., Waiczies, H., Peper, E., Huelnhagen, T., Seeliger, E., Schreiber, A., Kettritz, R., Strobel, K., Ku, M.C. and Waiczies, S.
Frontiers in Pharmacology 6 : 255. 12 November 2015

Review

Bradykinin B2 receptor signaling increases glucose uptake and oxidation: evidence and open questions.
Gregnani, M.F., Hungaro, T.G., Martins-Silva, L., Bader, M. and Araujo, R.C.
Frontiers in Pharmacology 11 : 1162. 4 August 2020

The trafficking of the water channel aquaporin-2 in renal principal cells-a potential target for pharmacological intervention in cardiovascular diseases.
Vukićević, T., Schulz, M., Faust, D. and Klussmann, E.
Frontiers in Pharmacology 7 : 23. 11 February 2016